Clinical Observation of Therapeutic Efficiency of Insulin Glargine Combined with Oral Hypoglycemic Agents in Elderly Patients with Type 2 Diabetes
HE Qi-shen
Abstract
HE Qi-shen
Abstract
Objective To evaluate the clinical observation of therapeutic efficiency and safty of insulin glargine combined with oral hypoglycemic agents in elderly patients with type 2 diabetes.Methods Fifty six elderly patients with type 2 diabetes and poorly glycemic control by oral medication were randomly divided into two groups:insulin glargine(+) group and isophane insulin(+) group.FBG,P2hBG,HbA1c and BMI in each group were measured before and after 24 weeks of treatment,and the adverse effect were also recorded.Results HbA1c,FBG and P2hBG of the two groups were declined obviously after 24 weeks of treatment,and the therapeutic equivalence between the two groups.No significant change of BMI in the two groups.But the incidence of severe hypoglycemia in the insulin glargine group was lower than that in the isophane insulin group.Conclusion The therapeutic equivalence of insulin glargine and isophane insulin in decreasing the blood sugar was observed,but the security in insulin glargine group was higher than that in the low protamine zinc insulin group.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the clinical observation of therapeutic efficiency and safty of insulin glargine combined with oral hypoglycemic agents in elderly patients with type 2 diabetes.Methods Fifty six elderly patients with type 2 diabetes and poorly glycemic control by oral medication were randomly divided into two groups:insulin glargine(+) group and isophane insulin(+) group.FBG,P2hBG,HbA1c and BMI in each group were measured before and after 24 weeks of treatment,and the adverse effect were also recorded.Results HbA1c,FBG and P2hBG of the two groups were declined obviously after 24 weeks of treatment,and the therapeutic equivalence between the two groups.No significant change of BMI in the two groups.But the incidence of severe hypoglycemia in the insulin glargine group was lower than that in the isophane insulin group.Conclusion The therapeutic equivalence of insulin glargine and isophane insulin in decreasing the blood sugar was observed,but the security in insulin glargine group was higher than that in the low protamine zinc insulin group.
Key concepts: Medicine, Insulin glargine, Hypoglycemia, Internal medicine, Insulin, Glycemic, Diabetes mellitus, Therapeutic effect